Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATRA | AMGN | BMY | GILD | VRTX |
| Company | Atara Biotherap | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.6400 | 301.75 | 43.98 | 65.43 | 406.42 |
| High | 0.6499 | 302.91 | 44.26 | 66.14 | 415.67 |
| Low | 0.5790 | 298.51 | 43.83 | 65.16 | 394.03 |
| Last | 0.6026 | 300.30 | 44.04 | 65.46 | 410.24 |
| Change | -0.0272 | +0.82 | +0.14 | -0.08 | +7.74 |
| % Change | -4.32% | +0.27% | +0.32% | -0.12% | +1.92% |
| Volume | 1,661,894 | 2,451,925 | 10,975,557 | 7,240,200 | 1,613,804 |
| 20-Day Average Volume | 1,031,765 | 2,824,191 | 14,382,253 | 7,601,965 | 1,102,520 |
| Previous Close | 0.6298 | 299.48 | 43.90 | 65.54 | 402.50 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.6864 | 275.28 | 46.72 | 66.46 | 398.63 |
| 20-Day Raw Stochastic | 13.04% | 63.99% | 8.89% | 20.81% | 77.98% |
| 20-Day Relative Strength | 40.35% | 63.04% | 29.94% | 34.46% | 54.47% |
| Weighted Alpha | -66.52 | +28.12 | -36.10 | -20.14 | +17.96 |
| Today's Opinion | 88% Sell | 40% Buy | 100% Sell | 100% Sell | 32% Buy |
| Previous Opinion | 72% Sell | 24% Buy | 100% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 24% Sell | 24% Sell | 32% Sell | 100% Sell | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.67% since 04/30/24 | +9.62% since 04/30/24 | +0.23% since 04/30/24 | +0.40% since 04/30/24 | +4.44% since 04/30/24 |
| Low | 0.5790 on 05/07/24 | 273.38 on 05/01/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 392.47 on 05/01/24 |
| High | 0.7600 on 05/01/24 | 322.60 on 05/03/24 | 44.62 on 05/06/24 | 66.14 on 05/07/24 | 415.67 on 05/07/24 |
| 1-Month | |||||
| %Chg | -22.15% since 04/05/24 | +11.24% since 04/05/24 | -14.19% since 04/05/24 | -5.92% since 04/05/24 | +0.88% since 04/05/24 |
| Low | 0.5790 on 05/07/24 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 0.8101 on 04/08/24 | 322.60 on 05/03/24 | 51.68 on 04/09/24 | 69.95 on 04/09/24 | 415.67 on 05/07/24 |
| 3-Month | |||||
| %Chg | -39.19% since 02/07/24 | +1.50% since 02/07/24 | -9.46% since 02/07/24 | -12.04% since 02/07/24 | -2.11% since 02/07/24 |
| Low | 0.5790 on 05/07/24 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 0.9998 on 02/08/24 | 322.60 on 05/03/24 | 55.03 on 03/13/24 | 76.21 on 03/11/24 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | -54.69% since 11/07/23 | +10.77% since 11/07/23 | -15.78% since 11/07/23 | -18.79% since 11/07/23 | +8.46% since 11/07/23 |
| Low | 0.1986 on 11/13/23 | 260.52 on 11/21/23 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 341.90 on 11/16/23 |
| High | 1.5800 on 02/02/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 75,838 | 160,633,888 | 88,989,688 | 81,602,352 | 104,029,752 |
| Shares Outstanding, K | 120,416 | 536,376 | 2,027,100 | 1,245,077 | 258,459 |
| Annual Sales | 8,570,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -276,130,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 4,250,000 | 7,447,000,000 | 11,865,000,000 | 6,686,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -60,450,000 | -113,000,000 | -11,911,000,000 | -4,170,000,000 | 968,800,000 |
| 60-Month Beta | 0.70 | 0.60 | 0.45 | 0.22 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.56 on 03/28/24 | 3.96 on 05/02/24 | -4.40 on 04/25/24 | -1.32 on 04/25/24 | 4.76 on 05/06/24 |
| Latest Earnings Date | 05/13/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.71 | 41.90 | 16.07 | 29.84 |